31 July 2018

GSK Stockmann contributed to the publication of the Chinese Outbound Investment Guide 2018

The Chinese Outbound Investment Guide 2018 has been published by International Financial Law Review (IFLR) and looks at the changes that have been occurring in Chinese outbound investment patterns and how target markets are adapting.

The guide covers numerous jurisdictions such as Bangladesh, France, Lebanon, Luxembourg, Offshore jurisdictions, South-Africa, Switzerland, Taiwan and Turkey, and examines the effects of the sudden acceleration in Chinese outbound investment over 2015 and 2016 across all sectors that underwent a fundamental change in 2017 to become more targeted. For each chapter, the publication provides a general outlook and looks into investment approval, investment techniques, dispute resolution, forex controls and local operations as well as tax.

GSK Stockmann contributed to the guide: Dr. Marcus Peter (lawyer and Partner at our GSK Stockmann office in Luxembourg) and Yi Wang (Associate at our GSK Stockmann office in Luxembourg) composed the chapter “Luxembourg“. 

The guide is now free to access on the adjoining Website.

Link : Chinese Outbound Investment Guide 2018 online

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 04.03.2022

    GSK Update: GSK Stockmann contributed to the publication of The Legal 500 Comparative Legal Guide – Luxembourg: Securitisation

    Read more
  • 10.02.2022

    GSK Update: Update of the Luxembourg Securitisation Law: Increased Flexibility and Legal Certainty

    Read more
  • 27.01.2022

    GSK Update: CSSF Guidance on Virtual Assets: New FAQ for UCI and credit institutions

    Read more
Contact person

Dr. Marcus Peter, LL.M.

Partner

+352 271802-50

marcus.peter@gsk-lux.com

© GSK Stockmann 2022